FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jean-Louis Achard

Research Profile

Disorders

Procedures

Concepts & Ideas

Chemicals & Drugs

Activities & Behaviors

Clinical Trials, Phase II as Topic

Co-author Network

Publications

TOP 3
E Monrigal; Marie-Ange Mouret-Reynier; Jean-Marc Nabholtz; M Peyronie; Jean-Louis Achard; Philippe Chollet; Jacques Dauplat; Pierre Gimbergues; Guillaume Le Bouedec; Christophe Pomel
Mastectomy with immediate breast reconstruction after neoadjuvant chemotherapy and radiation therapy. A new option for patients with operable invasive breast cancer. Results of a 20 years single institution study.
Frédérique Penault-Llorca; Catherine Abrial; Ines Raoelfils; Anne Cayre; Marie-Ange Mouret-Reynier; Marianne Leheurteur; Xavier Durando; Jean-Louis Achard; Pierre Gimbergues; Philippe Chollet
Comparison of the prognostic significance of Chevallier and Sataloff's pathologic classifications after neoadjuvant chemotherapy of operable breast cancer.
Véronique Dedieu; Corinne Bailly; Catherine Vincent; Jean-Louis Achard; Guillaume Le Bouedec; Frédérique Penault-Llorca; Pierre Verrelle; Dominique Vincensini
Capillary permeability and extracellular volume fraction in uterine cervical cancer as patient outcome predictors: measurements by using dynamic MRI spin-lattice relaxometry.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jean-Louis Achard (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: E Monrigal; Marie-Ange Mouret-Reynier; Jean-Marc Nabholtz; M Peyronie; Jean-Louis Achard; Philippe Chollet; Jacques Dauplat; Pierre Gimbergues; Guillaume Le Bouedec; Christophe Pomel
Mastectomy with immediate breast reconstruction after neoadjuvant chemotherapy and radiation therapy. A new option for patients with operable invasive breast cancer. Results of a 20 years single institution study.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2011;37(10):864-70.
2008: Frédérique Penault-Llorca; Catherine Abrial; Ines Raoelfils; Anne Cayre; Marie-Ange Mouret-Reynier; Marianne Leheurteur; Xavier Durando; Jean-Louis Achard; Pierre Gimbergues; Philippe Chollet
Comparison of the prognostic significance of Chevallier and Sataloff's pathologic classifications after neoadjuvant chemotherapy of operable breast cancer.
Human pathology 2008;39(8):1221-8.
2008: Véronique Dedieu; Corinne Bailly; Catherine Vincent; Jean-Louis Achard; Guillaume Le Bouedec; Frédérique Penault-Llorca; Pierre Verrelle; Dominique Vincensini
Capillary permeability and extracellular volume fraction in uterine cervical cancer as patient outcome predictors: measurements by using dynamic MRI spin-lattice relaxometry.
Journal of magnetic resonance imaging : JMRI 2008;27(4):846-53.
2007: Olivier Tacca; Frédérique Penault-Llorca; Catherine Abrial; Marie-Ange Mouret-Reynier; Inès Raoelfils; Xavier Durando; Jean-Louis Achard; Pierre Gimbergues; Hervé Curé; Philippe Chollet
Changes in and prognostic value of hormone receptor status in a series of operable breast cancer patients treated with neoadjuvant chemotherapy.
The oncologist 2007;12(6):636-43.
2006: Marie-Ange Mouret-Reynier; Catherine Abrial; Marianne Leheurteur; Xavier Durando; Isabelle Van Praagh; Pierre Gimbergues; Jean-Louis Achard; Jean-Pierre Ferrière; Hervé Cure; Philippe Chollet
[Indications, contra-indications, expected results and choice of neoadjuvant chemotherapy for operable breast cancer].
Bulletin du cancer 2006;93(11):1121-9.
2003: Sophie Amat; Philippe Bougnoux; Frédérique Penault-Llorca; F Fétissof; Hervé Curé; Fabrice Kwiatkowski; Jean-Louis Achard; G Body; Jacques Dauplat; Philippe Chollet
Neoadjuvant docetaxel for operable breast cancer induces a high pathological response and breast-conservation rate.
British journal of cancer 2003;88(9):1339-45.
2002: Philippe Chollet; Sophie Amat; Hervé Cure; Monique De Latour; Guillaume Le Bouedec; Marie-Ange Mouret-Reynier; Jean-Pierre Ferriere; Jean-Louis Achard; Jacques Dauplat; Frédérique Penault-Llorca
Prognostic significance of a complete pathological response after induction chemotherapy in operable breast cancer.
British journal of cancer 2002;86(7):1041-6.
2002: Sophie Amat; Frédérique Penault-Llorca; Hervé Cure; Guillaume Le Bouedëc; Jean-Louis Achard; Isabelle Van Praagh; Viviane Feillel; Marie-Ange Mouret-Reynier; Jacques Dauplat; Philippe Chollet
Scarff-Bloom-Richardson (SBR) grading: a pleiotropic marker of chemosensitivity in invasive ductal breast carcinomas treated by neoadjuvant chemotherapy.
International journal of oncology 2002;20(4):791-6.
2002: Isabelle Van Praagh; Hervé Cure; Bernard Leduc; Sabine Charrier; Guillaume Le Bouedec; Jean-Louis Achard; Jean-Pierre Ferriere; Viviane Feillel; Monique De Latour; Jacques Dauplat; Philippe Chollet
Efficacy of a primary chemotherapy regimen combining vinorelbine, epirubicin, and methotrexate (VEM) as neoadjuvant treatment in 89 patients with operable breast cancer.
The oncologist 2002;7(5):418-23.
1998: Jean-Pierre Ferrière; I Assier; Hervé Curé; Sabine Charrier; Fabrice Kwiatkowski; Jean-Louis Achard; Jacques Dauplat; Philippe Chollet
Primary chemotherapy in breast cancer: correlation between tumor response and patient outcome.
American journal of clinical oncology 1998;21(2):117-20.
1997: Jean-Pierre Ferrière; Sabine Charrier; Hervé Curé; Fabrice Kwiatkowski; M Courtadon; E Bélembaogo; Monique De Latour; Jean-Louis Achard; Jacques Dauplat; Philippe Chollet
Adjuvant chemotherapy with doxorubicin-containing regimen for 326 stage II breast cancers: 15-year results.
American journal of clinical oncology 1997;20(3):219-25.
1997: Hervé Cure; Sabine Charrier; Jean-Pierre Ferrière; Isabelle Van Praagh; I Assier; Viviane Feillel; Monique De Latour; Jacques-Olivier Bay; Jean-Louis Achard; Jacques Dauplat; Philippe Chollet
[First-line chemotherapy in operable breast neoplasms: results of 3 protocols].
Bulletin du cancer 1997;84(1):31-4.
1993: J Attia-Sobol; Jean-Pierre Ferrière; Hervé Curé; Fabrice Kwiatkowski; Jean-Louis Achard; Pierre Verrelle; Viviane Feillel; Monique De Latour; C Lafaye; C Deloche
Treatment results, survival and prognostic factors in 109 inflammatory breast cancers: univariate and multivariate analysis.
European journal of cancer (Oxford, England : 1990) 1993;29A(8):1081-8.
1992: E Bélembaogo; Viviane Feillel; Philippe Chollet; Hervé Curé; Pierre Verrelle; Fabrice Kwiatkowski; Jean-Louis Achard; Guillaume le Bouëdec; Jacques Chassagne; Yves-Jean Bignon
Neoadjuvant chemotherapy in 126 operable breast cancers.
European journal of cancer (Oxford, England : 1990) 1992;28A(4-5):896-900.
1991: M A Prouvost; M Canis; Guillaume le Bouëdec; Jean-Louis Achard; G Mage; Jacques Dauplat
[Ovarian transposition with per-celioscopy before curietherapy in stage IA and IB cancer of the uterine cervix].
Journal de gynécologie, obstétrique et biologie de la reproduction 1991;20(3):361-5.
1990: Jacques Dauplat; S Ben Ahmed; Jean-Louis Achard; Monique De Latour; Michel Legros; R Plagne
[Epithelial cancer of the ovary. Contribution of the experiences of a treatment facility to the current data of prognosis and treatment].
Journal de gynécologie, obstétrique et biologie de la reproduction 1990;19(3):247-60.
1988: C Dionet; R Rozan; Jean-Louis Achard; Pierre Verrelle; Y Dumesnil; M Russier; P Lemesle; H Theron; Monique De Latour; J M Mondie
Sequential combination of 5-fluorouracil, cis-platinum and irradiation. 1. Advanced head and neck cancers.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1988;11(2):123-31.
1988: C Dionet; Pierre Verrelle; D Roux; P Fraysse; Jean-Louis Achard; R Beaupain; R Rozan
Role of small doses of radiotherapy combined with chemotherapy in non-small cell lung cancer.
Antibiotics and chemotherapy 1988;41():163-7.